Odile Stalder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Odile Stalder has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Limacher
Department of Clinical Research, University of Bern, Bern, Switzerland
3 shared publications - Drahomir Aujesky
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
2 shared publications - Eric Vittinghoff
Department of Epidemiology and Biostatistics, University of California, San Francisco , San Francisco, CA 94158
2 shared publications - Julian Jakob
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
2 shared publications - Kali Tal
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
2 shared publications - Mark J. Pletcher
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA
2 shared publications
Latest Publications
- Open Access
- 1 April 2025
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 155 (4) , 4073
Well-being of the Swiss General Internal Medicine workforce: a nationwide survey
STUDY AIMS: Physician well-being is related to productivity and quality of care. The well-being of general internists (physicians who provide most primary care services) has never been comprehensively examined in Switzerland. In this survey, we assessed the well-being of Swiss general internists and its relationship to personal and work-related factors. METHODS: In November 2022, we conducted a national survey among members of the Swiss Society of General Internal Medicine. We evaluated the association between personal and work-related factors and reduced well-being (Physician Well-Being Index ≥4 points) using multivariable logistic regression. RESULTS: The response rate was 21% (1672/8111 members). Among the respondents whose data was analysed, 44% (710/1624) were women and 76% (1234/1613) primarily worked in an out-patient setting. Overall, 33% (543/1621) reported reduced well-being and 54% (876/1623) felt burnt out. Older age was associated with a lower likelihood of reduced well-being (adjusted odds ratio [aOR] 0.97, 95% confidence interval [CI] 0.96–0.98, per year) while being female was associated with a higher likelihood of reduced well-being (aOR 1.33, 95% CI 1.03–1.72). Factors associated with reduced well-being included working in an outpatient setting (aOR 1.76, 95% CI 1.24–2.51), having ≤2.5 personally rewarding working hours/day (aOR 2.18, 95% CI 1.63–2.90), long weekly working hours (aOR 1.02, 95% CI 1.01–1.03, per hour) and dissatisfaction with income (aOR 2.42, 95% CI 1.78–3.30). CONCLUSIONS: A third of Swiss general internists reported having a reduced well-being and approximately half felt burnt out. Female sex and several work-related factors such as working in an out-patient setting, long working hours, few personally rewarding work hours, and income dissatisfaction were related to having a reduced well-being.
- 1 April 2025
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 155 (4) , 4073
Open AccessWell-being of the Swiss General Internal Medicine workforce: a nationwide survey
STUDY AIMS: Physician well-being is related to productivity and quality of care. The well-being of general internists (physicians who provide most primary care services) has never been comprehensively examined in Switzerland. In this survey, we assessed the well-being of Swiss general internists and its relationship to personal and work-related factors. METHODS: In November 2022, we conducted a national survey among members of the Swiss Society of General Internal Medicine. We evaluated the association between personal and work-related factors and reduced well-being (Physician Well-Being Index ≥4 points) using multivariable logistic regression. RESULTS: The response rate was 21% (1672/8111 members). Among the respondents whose data was analysed, 44% (710/1624) were women and 76% (1234/1613) primarily worked in an out-patient setting. Overall, 33% (543/1621) reported reduced well-being and 54% (876/1623) felt burnt out. Older age was associated with a lower likelihood of reduced well-being (adjusted odds ratio [aOR] 0.97, 95% confidence interval [CI] 0.96–0.98, per year) while being female was associated with a higher likelihood of reduced well-being (aOR 1.33, 95% CI 1.03–1.72). Factors associated with reduced well-being included working in an outpatient setting (aOR 1.76, 95% CI 1.24–2.51), having ≤2.5 personally rewarding working hours/day (aOR 2.18, 95% CI 1.63–2.90), long weekly working hours (aOR 1.02, 95% CI 1.01–1.03, per hour) and dissatisfaction with income (aOR 2.42, 95% CI 1.78–3.30). CONCLUSIONS: A third of Swiss general internists reported having a reduced well-being and approximately half felt burnt out. Female sex and several work-related factors such as working in an out-patient setting, long working hours, few personally rewarding work hours, and income dissatisfaction were related to having a reduced well-being.
- Open Access
- 25 January 2023
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 7 (1) , 100015
Thrombophilia and outcomes of venous thromboembolism in older patients
- 25 January 2023
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 7 (1) , 100015
Open AccessThrombophilia and outcomes of venous thromboembolism in older patients
- Open Access
- 24 January 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (2) , 205-213
Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
Older patients anticoagulated for venous thromboembolism (VTE) have an increased risk of bleeding compared with younger patients. Little is known about the clinical impact of anticoagulation-related bleeding in this growing patient group. To prospectively assess the incidence, clinical impact, and predictors of bleeding in older patients anticoagulated for VTE, we analyzed 981 patients aged ≥65 years with acute VTE in a prospective multicenter cohort. Eight-eight percent were anticoagulated with vitamin K antagonists. Outcomes were the occurrence of major bleeding (MB) or clinically relevant nonmajor bleeding (CRNMB) event during the initial anticoagulation period up to 36 months. We described the incidence and clinical impact of bleeding and examined the association between risk factors and time to a first bleeding using competing risk regression; 100 MB and 125 CRNMB events occurred during follow-up. The incidence of MB and CRNMB was 8.5 (95% confidence interval [CI], 7.0-10.4) and 13.4 events (95% CI, 11.4-15.7) per 100 patient-years, respectively. In patients with MB, 79% required hospitalization, 18% required surgical intervention, and 19% required permanent discontinuation of anticoagulation; 15% of MB were intracranial and 6% were fatal. After adjustment, active cancer (subhazard ratio [SHR], 1.81; 95% CI, 1.12-2.93) and low physical activity (SHR, 1.88; 95% CI, 1.19-2.98) were associated with MB and high risk of falls with CRNMB (SHR, 2.04; 95% CI, 1.39-3.00). Older patients anticoagulated for VTE had a high incidence of MB and CRNMB, and these bleeding episodes caused a great burden of disease. Physicians should carefully weigh the risks/benefits of extended anticoagulation in the older population with VTE.
- 24 January 2023
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (2) , 205-213
Open AccessIncidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
Older patients anticoagulated for venous thromboembolism (VTE) have an increased risk of bleeding compared with younger patients. Little is known about the clinical impact of anticoagulation-related bleeding in this growing patient group. To prospectively assess the incidence, clinical impact, and predictors of bleeding in older patients anticoagulated for VTE, we analyzed 981 patients aged ≥65 years with acute VTE in a prospective multicenter cohort. Eight-eight percent were anticoagulated with vitamin K antagonists. Outcomes were the occurrence of major bleeding (MB) or clinically relevant nonmajor bleeding (CRNMB) event during the initial anticoagulation period up to 36 months. We described the incidence and clinical impact of bleeding and examined the association between risk factors and time to a first bleeding using competing risk regression; 100 MB and 125 CRNMB events occurred during follow-up. The incidence of MB and CRNMB was 8.5 (95% confidence interval [CI], 7.0-10.4) and 13.4 events (95% CI, 11.4-15.7) per 100 patient-years, respectively. In patients with MB, 79% required hospitalization, 18% required surgical intervention, and 19% required permanent discontinuation of anticoagulation; 15% of MB were intracranial and 6% were fatal. After adjustment, active cancer (subhazard ratio [SHR], 1.81; 95% CI, 1.12-2.93) and low physical activity (SHR, 1.88; 95% CI, 1.19-2.98) were associated with MB and high risk of falls with CRNMB (SHR, 2.04; 95% CI, 1.39-3.00). Older patients anticoagulated for VTE had a high incidence of MB and CRNMB, and these bleeding episodes caused a great burden of disease. Physicians should carefully weigh the risks/benefits of extended anticoagulation in the older population with VTE.
- Open Access
- 1 June 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (6) , 777-787.e9
Cumulative Marijuana Use and Carotid Intima-Media Thickness at Middle Age: The CARDIA Study
- 1 June 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (6) , 777-787.e9
Open AccessCumulative Marijuana Use and Carotid Intima-Media Thickness at Middle Age: The CARDIA Study
- Open Access
- 14 April 2021
- Published by The Open Journal in Journal of Open Source Software
- Vol. 6 (60) , 3118
presize: An R-package for precision-based sample size calculation in clinical research
- 14 April 2021
- Published by The Open Journal in Journal of Open Source Software
- Vol. 6 (60) , 3118
Open Accesspresize: An R-package for precision-based sample size calculation in clinical research
Association between marijuana use and electrocardiographic abnormalities by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study
Aims: To evaluate the prevalence of electrocardiogram (ECG) abnormalities in marijuana users as an indirect measure of subclinical cardiovascular disease (CVD). Design: Longitudinal and cross‐sectional secondary data analysis from the CARDIA (Coronary Artery Risk Development in Young Adults) study. Setting: Four communities in the United States. Participants: A total of 2585 participants from the 5115 black and white men and women recruited at age 18–30 years in 1985 to 1986 in CARDIA. Measurements: ECG abnormalities coded as minor and major abnormalities with the Minnesota code of electrocardiographic findings at year 20. Self‐reported current (past 30 days) and computed cumulative life‐time marijuana use (one ‘marijuana‐year’ corresponds to 365 days of use) through assessments every 2–5 years. We fitted logistic regression models adjusting for sex, race, center, education, age, tobacco smoking, physical activity, alcohol use and body mass index. Findings: Among the 2585 participants with an ECG at year 20, mean age was 46, 57% were women, 45% were black; 83% had past exposure to marijuana and 11% were using marijuana currently. One hundred and seventy‐three participants (7%) had major abnormalities and 944 (37%) had minor abnormalities. Comparing current with never use in multivariable‐adjusted models, the odds ratio (OR) for major ECG abnormalities was 0.60 [95% confidence interval (CI) = 0.32–1.15] and for minor ECG abnormalities 1.21 (95% CI = 0.87–1.68). Results did not change after stratifying by sex and race. Cumulative marijuana use was not associated with ECG abnormalities. Conclusion: In a middle‐aged US population, life‐time cumulative and occasional current marijuana use were not associated with increases in electrocardiogram abnormalities. This adds to the growing body of evidence that occasional marijuana use and cardiovascular disease events and markers of subclinical atherosclerosis are not associated.
Association between marijuana use and electrocardiographic abnormalities by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study
Aims: To evaluate the prevalence of electrocardiogram (ECG) abnormalities in marijuana users as an indirect measure of subclinical cardiovascular disease (CVD). Design: Longitudinal and cross‐sectional secondary data analysis from the CARDIA (Coronary Artery Risk Development in Young Adults) study. Setting: Four communities in the United States. Participants: A total of 2585 participants from the 5115 black and white men and women recruited at age 18–30 years in 1985 to 1986 in CARDIA. Measurements: ECG abnormalities coded as minor and major abnormalities with the Minnesota code of electrocardiographic findings at year 20. Self‐reported current (past 30 days) and computed cumulative life‐time marijuana use (one ‘marijuana‐year’ corresponds to 365 days of use) through assessments every 2–5 years. We fitted logistic regression models adjusting for sex, race, center, education, age, tobacco smoking, physical activity, alcohol use and body mass index. Findings: Among the 2585 participants with an ECG at year 20, mean age was 46, 57% were women, 45% were black; 83% had past exposure to marijuana and 11% were using marijuana currently. One hundred and seventy‐three participants (7%) had major abnormalities and 944 (37%) had minor abnormalities. Comparing current with never use in multivariable‐adjusted models, the odds ratio (OR) for major ECG abnormalities was 0.60 [95% confidence interval (CI) = 0.32–1.15] and for minor ECG abnormalities 1.21 (95% CI = 0.87–1.68). Results did not change after stratifying by sex and race. Cumulative marijuana use was not associated with ECG abnormalities. Conclusion: In a middle‐aged US population, life‐time cumulative and occasional current marijuana use were not associated with increases in electrocardiogram abnormalities. This adds to the growing body of evidence that occasional marijuana use and cardiovascular disease events and markers of subclinical atherosclerosis are not associated.